打破障碍:在自身免疫性疾病管理中推进细胞疗法
Yanhong Fu1,2, Chunjing Feng2,3, Shan Qin1,2
1School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China.
Frontiers in immunology
|December 16, 2024
概括
细胞疗法显示,通过向有害的免疫细胞来治疗自身免疫性疾病具有前景. 本综述探讨了这些创新治疗的最新进展和未来方向.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 治疗方法 治疗方法
背景情况:
- 自身免疫性疾病是由于免疫系统的失调导致的,攻击身体自身的组织.
- 目前的治疗方法提供了息治疗,缺乏对类风湿性关节炎和狼等疾病的确切治疗方法.
- 细胞疗法在瘤学中取得了成功,目前正在针对自身免疫性疾病进行研究.
研究的目的:
- 审查针对自身免疫性疾病的细胞疗法的最新进展.
- 讨论针对自反应性B细胞和T细胞的潜力.
- 建议未来的新疗法开发战略.
主要方法:
- 关于细胞疗法在自身免疫性疾病治疗中的当前文献的综述.
- 对自身反应性免疫细胞 (例如CD19,BCMA,CD20,CTLA-4) 的向策略的分析.
- 探索最近的临床应用和结果.
主要成果:
- 细胞疗法在自身免疫性疾病中显示出调节免疫反应的潜力.
- 针对自身反应性淋巴细胞上的特定细胞表面标记物是关键策略.
- 新出现的数据表明,在各种自身免疫性疾病中具有有效性.
结论:
- 细胞疗法在自身免疫性疾病管理中是一个有前途的前沿.
- 需要进一步的研究来优化向和治疗策略.
- 新型细胞治疗方法可能提供疾病修饰治疗.
关键词:
B 细胞 B 细胞 B 细胞CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19这是Tregs.自身免疫性疾病 自身免疫性疾病细胞疗法是细胞疗法.更多相关视频
相关概念视频
Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
Autoimmune Disorders
385
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
385
Cell-mediated Immune Responses
66.9K
Overview
66.9K
T Cell Types and Functions
947
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
947
Inflammatory Bowel Disease IV: Pharmacological Management
111
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
111
T Cell Activation and Clonal Selection
655
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
655


